Form 4: Mirion Technologies Chief Legal Officer Executes Stock Transactions Under 10b5-1 Plan
SEC Form 4
Emmanuelle Lee, Chief Legal Officer of Mirion Technologies, executed transactions involving Class A and Class B Common Stock through the Lee Revocable Living Trust under a pre-arranged 10b5-1 trading plan.
Summary
- On June 26, 2024, Emmanuelle Lee, Chief Legal Officer of Mirion Technologies, engaged in transactions involving the company's Class A and Class B Common Stock.
- These transactions were executed through the Lee Revocable Living Trust, of which Ms. Lee and her spouse are trustees and beneficiaries.
- The transactions included the redemption of 5,000 shares of Class B Common Stock for 5,000 shares of Class A Common Stock, and the sale of 5,000 shares of Class A Common Stock at a price of $10.76 per share.
- These transactions were conducted under a Rule 10b5-1 trading plan adopted by the Lee Trust on March 7, 2024.
- Following these transactions, Ms. Lee indirectly owns 51,153 shares of Class B Common Stock through the Lee Trust, and directly owns 101,272 shares of Class A Common Stock and 138,193 shares of Class B Common Stock.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the filing simply reports transactions under a pre-existing 10b5-1 plan. There is no indication of positive or negative sentiment towards the company's prospects.
Industry Context
This filing is a routine disclosure of insider transactions. It is common for executives to use 10b5-1 plans to manage their stock sales and avoid accusations of insider trading. The transactions themselves don't necessarily indicate a positive or negative outlook for the company.
Key Dates
| Date | Description |
|---|---|
| 03/07/2024 | The Lee Trust adopted a Rule 10b5-1 trading plan. |
| 06/26/2024 | Date of the stock transactions (redemption and sale). |
| 06/27/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.